Patent details
EP3150256 Title: COMBINATION OF ANTI-CD20 ANTIBODY AND PI3 KINASE SELECTIVE INHIBITOR
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- EP3150256
- WO Application Number:
- Type:
- European Patent Granted for NL
- Status:
- Lapsed by non-payment of annual fee Art. 62 ROW
- Publication Title:
- Title When Made Available For Viewing:
- Reason Lapsed:
- Application number:
- EP16185090.4
- WO Publication Number:
- EPO Publication Language:
- English
- SPC Number:
- First Applicant Residence Country:
- United States of America (US)
- Publications:
Dates
- Filing date:
- 01/11/2013
- Grant date:
- 15/07/2020
- EP Publication Date:
- 05/04/2017
- WO Publication Date:
- Claims Translations Received Date:
- Claims Translation B1 Received Date:
- 24/08/2020
- Claims Translation B2 Received Date:
- Claims Translation B3 Received Date:
- Lapsed By Non Payment Annual Fee Date:
- 01/12/2022
- Renunciation Date:
- NullificationDate:
- Published:
- Due To Cession Date:
- Registration date:
- 15/07/2020
- EP B1 Publication Date:
- 15/07/2020
- EP B2 Publication Date:
- EP B3 Publication Date:
- Description Translation B1 Received Date:
- Description Translation B2 Received Date:
- Description Translation B3 Received Date:
- Expiration date:
- 31/10/2033
- Lapsed By Expiration Date:
- Patent Validated Date:
- 04/09/2020
- Revocation Date:
- Invalidity Date:
- Response To Novelty Search Report Received:
- Patent Granting Request:
- Lapsed date:
Applicant/holder
- From:
- 15/07/2020
- Name:
- TG Therapeutics Inc.
- Address:
- 2 Gransevoort Street, 9th Floor, New York, NY 10014, United States of America (US)
- From:
- 15/07/2020
- Name:
- Rhizen Pharmaceuticals S.A.
- Address:
- Fritz Courvoisier 40, 2300 La Chaux de Fonds, Switzerland (CH)
- From:
- 15/07/2020
- Name:
- Laboratoire Français du Fractionnement et des Biotechnologies
- Address:
- 3, avenue des Tropiques, ZA Courtaboeuf,, 91940 Les Ulis, France (FR)
Agent
- Name:
- dr. W.A.H.M. Van Borm
- From:
- 27/08/2020
- Address:
- DIPS Belgium bvba Jacobslaan 101, B-2980, ZOERSEL, Belgium (BE)
- To:
Inventor
1
- Name:
- Weiss, Michael
- Address:
- New York, NY 10014, United States of America (US)
2
- Name:
- Miskin, Hari
- Address:
- New York, NY 10014, United States of America (US)
3
- Name:
- Sportelli, Peter
- Address:
- New York, NY 10014, United States of America (US)
4
- Name:
- Vakkalanka, Swaroop K.V.S
- Address:
- 2300 La Chaux de Fonds, Switzerland (CH)
Priority
1
- Priority Patent Number:
- 4595CH2012
- Priority Date:
- 02/11/2012
- Priority Country:
- India (IN)
2
- Priority Patent Number:
- 201361771812 P
- Priority Date:
- 02/03/2013
- Priority Country:
- United States of America (US)
Classification
- IPC or IDT classification:
- A61K 31/519; A61K 39/395; A61K 45/06; A61P 35/00; A61P 37/00; C07K 16/28;
Publication
Bulletin
1
- Bulletin Heading:
- VRV
- Journal edition number:
- 27/23
- Publication date:
- 05/07/2023
- Description:
- Lapse or annulment
2
- Bulletin Heading:
- EP3
- Journal edition number:
- 37/20
- Publication date:
- 09/09/2020
- Description:
- European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
3
- Bulletin Heading:
- EP2
- Journal edition number:
- 29/20
- Publication date:
- 14/08/2020
- Description:
- European patents granted for the Netherlands
European Patent Bulletin
- Issue number:
- 202029
- Publication date:
- 15/07/2020
- Description:
- Grant (B1)
Annual Fee
- Annual Fee(s) Due Date:
- Annual Fee Number:
- Last Annual Payment Date:
- 19/10/2021
- Last Annual Fee Paid Number:
- 9
- Last Annual Fee Paid Amount:
- 340 Euro
- Payer:
- Master Data Center
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 03/09/2020 | Outgoing Correspondence | Letter no formal defects | 1 | /0/8/7/6/7/0800576780/docs/ep16185090.4_0_364744l271.pdf | ||
| 24/08/2020 | Claims | First filed claims | 9 | /0/8/7/6/7/0800576780/docs/ep16185090.4_1_claims20200824161502616.pdf |